Podcast
Questions and Answers
What is the primary goal of treating multiple sclerosis with disease-modifying therapy?
What is the primary goal of treating multiple sclerosis with disease-modifying therapy?
Which of the following is a late sign of multiple sclerosis?
Which of the following is a late sign of multiple sclerosis?
What is the purpose of evoked potential testing in diagnosing multiple sclerosis?
What is the purpose of evoked potential testing in diagnosing multiple sclerosis?
What is a common side effect of immunomodulatory therapy in multiple sclerosis?
What is a common side effect of immunomodulatory therapy in multiple sclerosis?
Signup and view all the answers
What is the name of the drug commonly used to treat chronic pain in multiple sclerosis?
What is the name of the drug commonly used to treat chronic pain in multiple sclerosis?
Signup and view all the answers
Which of the following is NOT a symptom of multiple sclerosis?
Which of the following is NOT a symptom of multiple sclerosis?
Signup and view all the answers
What is the term for the suppression of bone marrow function in multiple sclerosis?
What is the term for the suppression of bone marrow function in multiple sclerosis?
Signup and view all the answers
Why is it important to monitor liver and bone marrow function in patients with multiple sclerosis?
Why is it important to monitor liver and bone marrow function in patients with multiple sclerosis?
Signup and view all the answers
What is the primary mechanism of action for dopamine replacement drugs in the treatment of Parkinson's disease?
What is the primary mechanism of action for dopamine replacement drugs in the treatment of Parkinson's disease?
Signup and view all the answers
Which symptom indicates the necessity for a Parkinson's disease diagnosis?
Which symptom indicates the necessity for a Parkinson's disease diagnosis?
Signup and view all the answers
Which of the following is true regarding the urine and sweat changes associated with dopamine replacement therapy?
Which of the following is true regarding the urine and sweat changes associated with dopamine replacement therapy?
Signup and view all the answers
What is a significant risk associated with higher doses of dopamine replacement drugs?
What is a significant risk associated with higher doses of dopamine replacement drugs?
Signup and view all the answers
What distinguishes dopamine agonists from dopamine replacement drugs in their mechanism of action?
What distinguishes dopamine agonists from dopamine replacement drugs in their mechanism of action?
Signup and view all the answers
In treating Parkinson's disease, which of the following medications is preferable for improving motor function?
In treating Parkinson's disease, which of the following medications is preferable for improving motor function?
Signup and view all the answers
Which of the following symptoms is NOT a typical side effect of dopamine agonists?
Which of the following symptoms is NOT a typical side effect of dopamine agonists?
Signup and view all the answers
What is the rationale for using dopamine replacement drugs in the treatment of Parkinson's disease?
What is the rationale for using dopamine replacement drugs in the treatment of Parkinson's disease?
Signup and view all the answers
Which of the following is NOT a cardinal symptom of Parkinson's disease?
Which of the following is NOT a cardinal symptom of Parkinson's disease?
Signup and view all the answers
Which of the following diagnostic tools is MOST SPECIFIC for diagnosing Parkinson's disease?
Which of the following diagnostic tools is MOST SPECIFIC for diagnosing Parkinson's disease?
Signup and view all the answers
Which of the following statements regarding the cognitive impairment in Parkinson's disease is TRUE?
Which of the following statements regarding the cognitive impairment in Parkinson's disease is TRUE?
Signup and view all the answers
What is the significance of a patient exhibiting pill-rolling tremor in Parkinson's disease?
What is the significance of a patient exhibiting pill-rolling tremor in Parkinson's disease?
Signup and view all the answers
What is the underlying pathophysiological mechanism that leads to the characteristic motor symptoms of Parkinson's disease?
What is the underlying pathophysiological mechanism that leads to the characteristic motor symptoms of Parkinson's disease?
Signup and view all the answers
Which of the following motor symptoms is characteristic of the later stages of Parkinson's disease?
Which of the following motor symptoms is characteristic of the later stages of Parkinson's disease?
Signup and view all the answers
What is the role of a Dopamine Transporter scan in diagnosing Parkinson's disease?
What is the role of a Dopamine Transporter scan in diagnosing Parkinson's disease?
Signup and view all the answers
A patient with Parkinson's Disease (PD) is experiencing worsening motor symptoms. Which of the following actions is LEAST likely to be taken initially by the healthcare provider?
A patient with Parkinson's Disease (PD) is experiencing worsening motor symptoms. Which of the following actions is LEAST likely to be taken initially by the healthcare provider?
Signup and view all the answers
Which of the following is a potential adverse effect associated with dopamine agonists used for Parkinson's Disease?
Which of the following is a potential adverse effect associated with dopamine agonists used for Parkinson's Disease?
Signup and view all the answers
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option less suitable?
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option less suitable?
Signup and view all the answers
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Signup and view all the answers
Which of the following medications is a COMT inhibitor used in the treatment of Parkinson's Disease?
Which of the following medications is a COMT inhibitor used in the treatment of Parkinson's Disease?
Signup and view all the answers
Which of the following is a potential risk associated with a 'drug holiday' for a patient with Parkinson's Disease?
Which of the following is a potential risk associated with a 'drug holiday' for a patient with Parkinson's Disease?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing significant cognitive decline. Which of the following medications would MOST likely be considered to help manage the cognitive symptoms?
A patient with Parkinson's Disease is experiencing significant cognitive decline. Which of the following medications would MOST likely be considered to help manage the cognitive symptoms?
Signup and view all the answers
A patient with Parkinson's Disease presents with a shuffling gait, resting tremor, and rigidity. Which of the following motor symptoms is NOT typically associated with Parkinson's Disease?
A patient with Parkinson's Disease presents with a shuffling gait, resting tremor, and rigidity. Which of the following motor symptoms is NOT typically associated with Parkinson's Disease?
Signup and view all the answers
What is the most common cause of death for individuals with Parkinson's Disease?
What is the most common cause of death for individuals with Parkinson's Disease?
Signup and view all the answers
Which of the following medications is NOT typically used to treat urinary retention in patients with Multiple Sclerosis?
Which of the following medications is NOT typically used to treat urinary retention in patients with Multiple Sclerosis?
Signup and view all the answers
A patient with Parkinson's Disease presents with tremors, rigidity, and bradykinesia. What is the primary goal of treatment with dopamine replacement drugs?
A patient with Parkinson's Disease presents with tremors, rigidity, and bradykinesia. What is the primary goal of treatment with dopamine replacement drugs?
Signup and view all the answers
Which of the following is a potential adverse effect associated with the use of dopamine replacement drugs in patients with Parkinson's Disease?
Which of the following is a potential adverse effect associated with the use of dopamine replacement drugs in patients with Parkinson's Disease?
Signup and view all the answers
What is the primary mechanism of action for Baclofen (Lioresal) in the management of muscle spasms in patients with Multiple Sclerosis?
What is the primary mechanism of action for Baclofen (Lioresal) in the management of muscle spasms in patients with Multiple Sclerosis?
Signup and view all the answers
Which of the following is a commonly used medication to treat nausea and vomiting in patients with Multiple Sclerosis?
Which of the following is a commonly used medication to treat nausea and vomiting in patients with Multiple Sclerosis?
Signup and view all the answers
A patient with Parkinson's Disease experiences cognitive impairment. What is the most likely cause of this impairment?
A patient with Parkinson's Disease experiences cognitive impairment. What is the most likely cause of this impairment?
Signup and view all the answers
What is the best diagnostic tool for confirming a diagnosis of Parkinson's Disease?
What is the best diagnostic tool for confirming a diagnosis of Parkinson's Disease?
Signup and view all the answers
Which of the following is a potential adverse effect of dopamine agonists used in the treatment of Parkinson's Disease?
Which of the following is a potential adverse effect of dopamine agonists used in the treatment of Parkinson's Disease?
Signup and view all the answers
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option less suitable?
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option less suitable?
Signup and view all the answers
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Signup and view all the answers
Which of the following medications is a COMT inhibitor used in the treatment of Parkinson's Disease?
Which of the following medications is a COMT inhibitor used in the treatment of Parkinson's Disease?
Signup and view all the answers
Which of the following is a potential risk associated with a 'drug holiday' for a patient with Parkinson's Disease?
Which of the following is a potential risk associated with a 'drug holiday' for a patient with Parkinson's Disease?
Signup and view all the answers
A patient with Parkinson's Disease presents with a shuffling gait, resting tremor, and rigidity. Which of the following motor symptoms is NOT typically associated with Parkinson's Disease?
A patient with Parkinson's Disease presents with a shuffling gait, resting tremor, and rigidity. Which of the following motor symptoms is NOT typically associated with Parkinson's Disease?
Signup and view all the answers
What is the most common cause of death for individuals with Parkinson's Disease?
What is the most common cause of death for individuals with Parkinson's Disease?
Signup and view all the answers
A patient with Parkinson's Disease experiences cognitive impairment. What is the most likely cause of this impairment?
A patient with Parkinson's Disease experiences cognitive impairment. What is the most likely cause of this impairment?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing severe motor fluctuations, including periods of 'on' and 'off' symptoms. Which of the following treatment options is MOST likely to be considered to address these fluctuations?
A patient with Parkinson's Disease is experiencing severe motor fluctuations, including periods of 'on' and 'off' symptoms. Which of the following treatment options is MOST likely to be considered to address these fluctuations?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing hallucinations and delusions. Which of the following is the MOST likely explanation for these symptoms?
A patient with Parkinson's Disease is experiencing hallucinations and delusions. Which of the following is the MOST likely explanation for these symptoms?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing orthostatic hypotension. Which of the following medications is MOST likely to be the cause of this side effect?
A patient with Parkinson's Disease is experiencing orthostatic hypotension. Which of the following medications is MOST likely to be the cause of this side effect?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing significant dyskinesias, characterized by involuntary movements. Which of the following approaches is MOST appropriate to address this issue?
A patient with Parkinson's Disease is experiencing significant dyskinesias, characterized by involuntary movements. Which of the following approaches is MOST appropriate to address this issue?
Signup and view all the answers
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option LESS suitable?
A patient with Parkinson's Disease is being considered for treatment with dopamine agonists. Which of the following factors would make this treatment option LESS suitable?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing significant cognitive decline. Which of the following medications would MOST likely be considered to help manage the cognitive symptoms?
A patient with Parkinson's Disease is experiencing significant cognitive decline. Which of the following medications would MOST likely be considered to help manage the cognitive symptoms?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing constipation. Which of the following medications is MOST likely to be the cause of this side effect?
A patient with Parkinson's Disease is experiencing constipation. Which of the following medications is MOST likely to be the cause of this side effect?
Signup and view all the answers
A patient with Parkinson's Disease is experiencing tremors, rigidity, and bradykinesia. What is the PRIMARY goal of treatment with dopamine replacement drugs?
A patient with Parkinson's Disease is experiencing tremors, rigidity, and bradykinesia. What is the PRIMARY goal of treatment with dopamine replacement drugs?
Signup and view all the answers
Which class of medication is preferred for younger patients concerned with drug-induced dyskinesias?
Which class of medication is preferred for younger patients concerned with drug-induced dyskinesias?
Signup and view all the answers
What is a significant adverse effect associated with dopamine agonists?
What is a significant adverse effect associated with dopamine agonists?
Signup and view all the answers
What is a potential strategy for managing drug tolerance in patients with Parkinson's disease?
What is a potential strategy for managing drug tolerance in patients with Parkinson's disease?
Signup and view all the answers
Which medication class inhibits the breakdown of levodopa?
Which medication class inhibits the breakdown of levodopa?
Signup and view all the answers
Which of the following medications is used to protect levodopa from being broken down?
Which of the following medications is used to protect levodopa from being broken down?
Signup and view all the answers
Which of the following is a risk associated with a 'drug holiday' for patients with Parkinson's Disease?
Which of the following is a risk associated with a 'drug holiday' for patients with Parkinson's Disease?
Signup and view all the answers
What is the primary benefit of using catechol-O-methyltransferase inhibitors?
What is the primary benefit of using catechol-O-methyltransferase inhibitors?
Signup and view all the answers
What is the function of monoamine oxidase-B inhibitors in the treatment of Parkinson's disease?
What is the function of monoamine oxidase-B inhibitors in the treatment of Parkinson's disease?
Signup and view all the answers
A patient with Parkinson's Disease (PD) presents with bradykinesia, rigidity, and resting tremor. Which of the following statements BEST describes the underlying pathophysiological mechanism causing these symptoms?
A patient with Parkinson's Disease (PD) presents with bradykinesia, rigidity, and resting tremor. Which of the following statements BEST describes the underlying pathophysiological mechanism causing these symptoms?
Signup and view all the answers
A patient with PD has been taking levodopa for several years. They are now experiencing worsening motor fluctuations, including 'on-off' periods. Which of the following is the MOST likely explanation for these fluctuations?
A patient with PD has been taking levodopa for several years. They are now experiencing worsening motor fluctuations, including 'on-off' periods. Which of the following is the MOST likely explanation for these fluctuations?
Signup and view all the answers
Which of the following medications is MOST likely to be considered as a first-line treatment for a patient with newly diagnosed PD, exhibiting mild motor symptoms?
Which of the following medications is MOST likely to be considered as a first-line treatment for a patient with newly diagnosed PD, exhibiting mild motor symptoms?
Signup and view all the answers
A patient with PD is experiencing severe motor fluctuations and dyskinesia despite optimal levodopa therapy. Which of the following treatment strategies is MOST likely to be considered next?
A patient with PD is experiencing severe motor fluctuations and dyskinesia despite optimal levodopa therapy. Which of the following treatment strategies is MOST likely to be considered next?
Signup and view all the answers
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Which of the following statements BEST describes the mechanism of action of MAOB inhibitors in the treatment of Parkinson's Disease?
Signup and view all the answers
A patient with PD is experiencing significant orthostatic hypotension. Which of the following medications is MOST likely to be contributing to this side effect?
A patient with PD is experiencing significant orthostatic hypotension. Which of the following medications is MOST likely to be contributing to this side effect?
Signup and view all the answers
Which of the following options accurately describes the mechanism by which dopamine replacement drugs exert their therapeutic effect in Parkinson's disease?
Which of the following options accurately describes the mechanism by which dopamine replacement drugs exert their therapeutic effect in Parkinson's disease?
Signup and view all the answers
A patient with Parkinson's disease is experiencing worsening motor symptoms despite taking levodopa. Which of the following is a potential reason for this phenomenon?
A patient with Parkinson's disease is experiencing worsening motor symptoms despite taking levodopa. Which of the following is a potential reason for this phenomenon?
Signup and view all the answers
Which of the following medications is commonly used in conjunction with levodopa to prolong its therapeutic effect and reduce the development of dyskinesia?
Which of the following medications is commonly used in conjunction with levodopa to prolong its therapeutic effect and reduce the development of dyskinesia?
Signup and view all the answers
A patient with Parkinson's disease is experiencing significant fluctuations in motor function, including "on-off" periods of mobility and immobility. What medication strategy might be considered to address these fluctuations?
A patient with Parkinson's disease is experiencing significant fluctuations in motor function, including "on-off" periods of mobility and immobility. What medication strategy might be considered to address these fluctuations?
Signup and view all the answers
Which of the following statements is TRUE regarding the use of dopamine agonists in the treatment of Parkinson's disease?
Which of the following statements is TRUE regarding the use of dopamine agonists in the treatment of Parkinson's disease?
Signup and view all the answers
Which of the following side effects is MOST commonly associated with the use of dopamine agonists in the treatment of Parkinson's disease?
Which of the following side effects is MOST commonly associated with the use of dopamine agonists in the treatment of Parkinson's disease?
Signup and view all the answers
A patient with Parkinson's disease is being considered for treatment with a MAOB inhibitor. Which of the following conditions would make this treatment option less suitable?
A patient with Parkinson's disease is being considered for treatment with a MAOB inhibitor. Which of the following conditions would make this treatment option less suitable?
Signup and view all the answers
Which of the following medications is a COMT inhibitor that is commonly used in the treatment of Parkinson's disease to prolong the duration of action of levodopa?
Which of the following medications is a COMT inhibitor that is commonly used in the treatment of Parkinson's disease to prolong the duration of action of levodopa?
Signup and view all the answers
Which of the following statements is TRUE regarding the use of a "drug holiday" in the management of Parkinson's disease?
Which of the following statements is TRUE regarding the use of a "drug holiday" in the management of Parkinson's disease?
Signup and view all the answers
Study Notes
Parkinson's Disease (PD)
- Progressive neurodegenerative disorder
- Death usually occurs secondary to pulmonary or renal disease
- Considered an unsafe disease
Pathophysiology of PD
- Depletion of dopamine, necessary for controlling posture and voluntary movement
- Dopamine is required for muscle relaxation, while acetylcholine is required to contract muscles
Signs and Symptoms of PD
- Characterized by 4 cardinal symptoms: tremor, muscle rigidity, bradykinesia or akinesia, and postural instability
- Other symptoms: muscle weakness, masklike appearance of face, drooling, impaired judgment, emotional instability, change in cognition, and psychosis (late)
- Having 2 or more symptoms equals a Parkinson's diagnosis
- Tremors are a huge symptom
- Bradykinesia means slow or low movement, while akinesia means the patient is unable to move (late stage)
- Great risk for falls
Diagnosis of PD
- No specific diagnostic tests
- Dopamine transporter scan (newer) uses a radioactive agent that binds to dopamine transporter
- CSF may show decreased dopamine levels
- Single-photon emission computed tomography (SPECT) may show loss of dopamine-producing neurons
Treatment of PD
- Medications: Dopamine Replacement Drugs and Dopamine Agonists
- Dopamine Replacement Drugs:
- Mechanism of action: increase the amount of dopamine available in the body
- Names: levodopa/carbidopa (Sinemet)
- Side effects: nausea, vomiting, darkened urine and sweat, dyskinesias
- Potential adverse effects: postural hypotension (orthostatic), psychosis
- Nursing considerations: educate patient on long-term use and dyskinesias, preferred for improving motor function
- Dopamine Agonists:
- Mechanism of action: directly activates dopamine receptors
- Names: bromocriptine (Parlodel)
- Side effects: nausea, dizziness, constipation, weakness, hallucinations
- Potential adverse effects: daytime sleepiness, postural hypotension (orthostatic), weight gain
Multiple Sclerosis (MS)
- Progressive and unpredictable disease
- Signs and symptoms:
- Visual changes
- Tremors
- Weakness
- Fatigue
- Paresthesia
- Ataxia (gait, fine motor)
- Dysarthria, dysphagia
- Bowel and bladder dysfunction
- Cognitive changes
- Memory impairment (late)
- Teach patients to report symptoms immediately for treatment
- Acute decrease in function; with treatment, symptoms go away
- Can aspirate due to dysphagia
- Uncoordinated gait = ataxia, risk for falls
- Trouble speaking = dysarthria, dysphagia
- Bowel and bladder dysfunction = nerves not working
- Memory impairment = late sign of MS
- Baclofen is commonly used for MS
Psychosocial Concerns: MS
- Length of diagnosis and misdiagnosis can lead to relief, anger, or frustration
- After diagnosis, patients may experience anxiety, depression, and sexual dysfunction
- Promote open communication and assess for coping mechanisms and stress management
Interventions (Responding): MS
- Disease-modifying therapy
- Medications to treat symptoms
- Frequent assessment of liver and bone marrow function
- Use of disease-modifying drugs (DMD)
- Education on meds, what to look out for, and what to avoid
Diagnostic Tests for MS
- MRI
- Presence of IgG and elevated WBC in CSF
- Elevated IgG in serum
- Evoked potential testing
- No golden standard due to nonspecific symptoms
- White plaque on MRI indicates possible MS
- Blood work is important to see elevated IgG in serum
- Evoked potential testing mostly assesses damage
Disease-Modifying Drugs: Immunomodulators
- Mechanism of action: adjusts the immune response
- Names: interferon beta-1a (Avonex), dimethyl fumarate (Tecfidera), glatiramer acetate (Copaxon), natalizumab (Tysabri), fingolimod (Gilenya), teriflunomide (Aubagio)
- Side effects: headaches, GI distress (constipation), fatigue, infections, liver damage
- Potential adverse effects: bone marrow suppression, anaphylaxis, severe tissue injury
- Treatment should continue indefinitely
- If patient concerned with drug-induced dyskinesias, dopamine agonists preferred
Supplemental Meds for PD
- Monoamine oxidase-B (MAOB) inhibitors: selegiline (Eldepryl), rasagiline (Azilect)
- Catechol-O-Methyltransferase (COMT) inhibitors: entacapone (Comtan), tolcapone (Tasmar)
- Protects levodopa that changes into dopamine
Parkinson's Disease (PD)
- Progressive neurodegenerative disorder
- Death usually occurs secondary to pulmonary or renal disease
- Depletion of dopamine, the neurotransmitter required to control posture and voluntary movement
- Dopamine is required for muscle relaxation, while acetylcholine is required to contract muscles
- Symptoms:
- 4 cardinal symptoms: tremor, muscle rigidity, bradykinesia or akinesia, and postural instability
- Muscle weakness, masklike appearance of face, drooling, impaired judgment, and emotional instability
- Change in cognition and psychosis (late stage)
- Diagnosis: no specific diagnostic tests, but presentation of 2 or more symptoms equals a Parkinson's diagnosis
- Medications:
- Dopamine Replacement Drugs (e.g. levodopa/carbidopa): increase dopamine in the body
- Side effects: nausea, vomiting, darkened urine and sweat, dyskinesias, postural hypotension, and psychosis
- Dopamine Agonists (e.g. bromocriptine): directly activate dopamine receptors
- Side effects: nausea, dizziness, constipation, weakness, hallucinations, daytime sleepiness, and postural hypotension
- Supplemental meds: Monoamine oxidase-B (MAO-B) Inhibitors (e.g. selegiline, rasagiline) and Catechol-O-Methyltransferase (COMT) Inhibitors (e.g. entacapone, tolcapone)
- Dopamine Replacement Drugs (e.g. levodopa/carbidopa): increase dopamine in the body
Multiple Sclerosis (MS)
- Progressive neurodegenerative disorder
- Death usually occurs secondary to pulmonary or renal disease
- Signs and symptoms:
- Visual changes, tremors, weakness, fatigue, paresthesia, ataxia, dysarthria, dysphagia, bowel and bladder dysfunction, and cognitive changes
- Remissions and exacerbations
- Psychosocial concerns:
- Length of diagnosis, misdiagnosis, and relief vs anger/frustration upon diagnosis
- Anxiety, depression, and sexual dysfunction after diagnosis
- Nonspecific disease with often tired and fatigued patients
- Interventions:
- Disease Modifying Therapy (DMT): no cure, but meds to treat symptoms
- Frequent assessment of liver and bone marrow function
- Physical and occupational therapy, and medical marijuana
- Diagnostic tests:
- MRI, presence of IgG and elevated WBC in CSF, elevated IgG in serum, and evoked potential testing
- Disease Modifying Drugs:
- Immunomodulators: adjust the immune response
- Examples: interferon beta-1a, dimethyl fumarate, glatiramer acetate, natalizumab, fingolimod, and teriflunomide
- Side effects: headaches, GI distress, fatigue, infections, liver damage, bone marrow suppression, anaphylaxis, and severe tissue injury
- Immunomodulators: adjust the immune response
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the symptoms and diagnosis of Parkinson's disease, including the role of dopamine levels in CSF, and treatment options using dopamine replacement drugs.